Next Science Limited (NXS) 2022年年度报告「ASX」.pdf

1、Next Science Limited ACN:622 382 549 Appendix 4E 31 December 2022 Company details Name of entity:Next Science Limited ABN:47 622 382 549 Reporting period:For the year ended 31 December 2022 Previous period:For the year ended 31 December 2021 _ Results for announcement to the market USD$Revenues from

2、 ordinary activities up 31%to 11,712,722 Loss from ordinary activities after tax attributable to the owners of Next Science Limited up 36%to (12,683,312)Loss for the year attributable to the owners of Next Science Limited up 36%to (12,683,312)Dividends No dividend was paid or proposed during the yea

3、r ended 31 December 2022(2021:USD$nil).Refer to the Operating and Financial Review within the Directors Report for further commentary on the years results,financial position and likely developments in future years.Net tangible assets Reporting period USD Cents Previous period USD Cents Net tangible

4、assets/(liabilities)per ordinary security 2.62 4.16 The net tangible asset/(liability)per ordinary security is calculated based on 214,790,134 ordinary shares on issue at 31 December 2022 and 197,973,909 shares that were in existence at 31 December 2021.Control gained over entities Not applicable.Lo

5、ss of control over entities Not applicable.Next Science Limited ACN:622 382 549 Appendix 4E 31 December 2021 Other information requiring disclosure to comply with ASX Listing rule 4.3A is contained in,and should be read in conjunction with the Financial Statements,the notes to the Financial Statemen

6、ts and the Directors Report for the year ended 31 December 2022 attached to this report.This report is based on the Consolidated Financial Statements and Notes of Next Science Limited which have been audited by KPMG.Signed Mark Compton,AM Chair 28 February 2023 Sydney Next Science Limited ACN 622 38